Registry Stop Signal

Topical Tazarotene

Topical Tazarotene is flagged as registry stop signal because public records show a registry stop signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Solid Tumor

Mechanism: Unknown

Modality: Unknown

Sponsor: Dana-Farber Cancer Institute

Scores

Risk-signal summary

Registry: 5/5

Timeline: 1/5

Recruitment burden: 0/5

Results availability: 0/5

Program risk: 3/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT04071756

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT04071756Registry Stop Signal (TERMINATED)stale_update_signalLow SignalNone